Skip to main content

Cutaneous Adverse Drug Reactions in Pediatric Population

  • Chapter
  • First Online:
Book cover Advances in Diagnosis and Management of Cutaneous Adverse Drug Reactions

Abstract

Cutaneous adverse drug reactions (CADR) are the most common drug reactions in the pediatric population. Several aspects of CADR and other rashes are more unique to children and impact the diagnosis and management of CADRs in this population. Such factors include different age groups, each with unique features, concurrent viral/bacterial illnesses which could be associated with an exanthem and age-specific pharmacokinetics. The proportional dominance of offending drug classes is different than in adults—anti-infectives make the majority, followed by antipyretics and antiepileptics. In this chapter, unique CADR features in the pediatric population are discussed, and a morphologic approach, based on simple and complex/severe eruptions, is suggested.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

ADR:

Adverse drug reactions

AGEP:

Acute generalized exanthematous pustulosis

cADR:

Cutaneous adverse drug reactions

CPNDS:

Canadian pharmacogenomics network for drug safety

DIHS:

Drug-induced hypersensitivity syndrome

DRESS:

Drug reaction with eosinophilia and systemic symptoms

EM:

Erythema multiforme

GI:

Gastrointestinal

JIA:

Juvenile idiopathic arthritis

MIRM:

Mycoplasma-induced rash and mucositis

NICUs:

Neonatal intensive care units

NSAIDs:

Nonsteroidal anti-inflammatory drugs

SJS/TEN:

Stevens–Johnson syndrome/toxic epidermal necrolysis

SSLR:

Serum sickness-like reactions

References

  • Alerhand S, Cassella C, Koyfman A (2016) Stevens-Johnson syndrome and toxic epidermal necrolysis in the pediatric population: a review. Pediatr Emerg Care 32(7):472–476

    Article  PubMed  Google Scholar 

  • Aljebab F, Choonara I, Conroy S (2017) Systematic review of the toxicity of long-course oral corticosteroids in children. PLoS One 12(1):e0170259. https://doi.org/10.1371/journal.pone.0170259 eCollection 2017

    Article  PubMed Central  PubMed  Google Scholar 

  • Anderson GD (2002) Children versus adults: pharmacokinetic and adverse-effect differences. Epilepsia 43(Suppl 3):53–59

    Article  CAS  PubMed  Google Scholar 

  • Avner M, Finkelstein Y, Hackam D, Koren G (2007) Establishing causality in pediatric adverse drug reactions. Pediatr Drugs 9(4):267–270

    Article  Google Scholar 

  • Canavan TN, Mathes EF, Frieden I, Shinkai K (2015) Mycoplasma pneumoniae-induced rash and mucositis as a syndrome distinct from Stevens-Johnson syndrome and erythema multiforme: a systematic review. J Am Acad Dermatol 72(2):239–245. https://doi.org/10.1016/j.jaad.2014.06.026

    Article  PubMed  Google Scholar 

  • Castro-Pastrana LI, Ghannadan R, Rieder MJ, Dahlke E, Hayden M, Carleton B (2011) Cutaneous adverse drug reactions in children: an analysis of reports from the Canadian pharmacogenomics network for drug safety (CPNDS). J Popul Ther Clin Pharmacol 18:e106–e120

    PubMed  Google Scholar 

  • Catt CJ, Hamilton GM, Fish J, Mireskandari K, Ali A (2016) Ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis in children. Am J Ophthalmol 166:68–75. https://doi.org/10.1016/j.ajo.2016.03.020

    Article  PubMed  Google Scholar 

  • Conroy S, Choonara I, Impicciatore P et al (2000) Survey of unlicensed and off label drug use in paediatric wards in European countries. European network for drug investigation in children. BMJ 320:79–82

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • De Silva B, Banney L, Uttley W, Luqmani R, Schofield O (2000) Pseudoporphyria and nonsteroidal antiinflammatory agents in children with juvenile idiopathic arthritis. Pediatr Dermatol 17(6):480–483

    Article  PubMed  Google Scholar 

  • Dibek Misirlioglu E, Guvenir H, Bahceci S, Haktanir Abul M, Can D, Usta Guc BE, Erkocoğlu M, Toyran M, Nacaroglu HT, Civelek E, Buyuktiryaki B, Ginis T, Orhan F, Kocabas CN (2017) Severe cutaneous adverse drug reactions in pediatric patients: a multicenter study. J Allergy Clin Immunol Pract 5:757. https://doi.org/10.1016/j.jaip.2017.02.013

    Article  PubMed  Google Scholar 

  • Dilek N, Özkol HU, Akbaş A, Kılınç F, Dilek AR, Saral Y, Metin A, Çalka Ö (2014) Cutaneous drug reactions in children: a multicentric study. Postep Derm Alergol XXXI(6):368–371

    Google Scholar 

  • Drago F, Paolino S, Rebora A, Broccolo F, Drago F, Cardo P, Parodi A (2012) The challenge of diagnosing atypical exanthems: a clinico-laboratory study original research article. J Am Acad Dermatol 67(6):1282–1288

    Article  PubMed  Google Scholar 

  • Du W, Lehr VT, Lieh-Lai M, Koo W, Ward RM, Rieder MJ, Van Den Anker JN, Reeves JH, Mathew M, Lulic-Botica M, Aranda JV (2013) An algorithm to detect adverse drug reactions in the neonatal intensive care unit. J Clin Pharmacol 53(1):87–95. https://doi.org/10.1177/0091270011433327

    Article  PubMed  Google Scholar 

  • Emer JJ, Bernardo SG, Kovalerchik O, Ahmad M (2013) Urticaria multiforme. J Clin Aesthet Dermatol 6(3):34–39

    PubMed Central  PubMed  Google Scholar 

  • Ferrero NA, Pearson KC, Zedek DC et al (2013) Case report of drug rash with eosinophilia and systemic symptoms demonstrating human herpesvirus-6 reactivaion. Pediatr Dermatol 30(5):608–613

    Article  PubMed  Google Scholar 

  • Finkelstein Y, Soon GS, Acuna P, George M, Pope E, Ito S, Shear NH, Koren G, Shannon MW, Garcia-Bournissen F (2011) Recurrence and outcomes of Stevens-Johnson syndrome and toxic epidermal necrolysis in children. Pediatrics 128(4):723–728

    Article  PubMed  Google Scholar 

  • Food and Drug Administration (2001) The pediatric exclusivity provision: January 2001 status report to congress. Food and Drug Administration, Rockville, MD

    Google Scholar 

  • Gul Mert G, Incecik F, Gunasti S, Herguner O, Altunbasak S (2013) Psoriasiform drug eruption associated with sodium valproate. Case Rep Pediatr 2013:823469

    PubMed Central  PubMed  Google Scholar 

  • Heelan K, Shear NH (2013) Cutaneous drug reactions in children: an update. Pediatr Drugs 15:493–503

    Article  Google Scholar 

  • Hsu DY, Brieva J, Silverberg NB, Paller AS, Silverberg JI (2017) Pediatric Stevens-Johnson syndrome and toxic epidermal necrolysis in the United States. J Am Acad Dermatol 76(5):811–817.e4. https://doi.org/10.1016/j.jaad.2016.12.024

    Article  PubMed Central  PubMed  Google Scholar 

  • Husain Z, Reddy BY, Schwartz RA (2013) DRESS syndrome: Part I Clinical perspectives. J Am Acad Dermatol 68(5):693.e1–693.14. https://doi.org/10.1016/j.jaad.2013.01.033; quiz 706–8.

    Article  CAS  Google Scholar 

  • Kardaun SH, Sekula P, Valeyrie-Allanore L et al (2013) Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol 169(5):1071–1080

    Article  CAS  PubMed  Google Scholar 

  • Kazandjieva J, Tsankov N (2017) Drug-induced acne. Clin Dermatol 35(2):156–162

    Article  PubMed  Google Scholar 

  • Lansang P, Weinstein M, Shear N (2011) Drug reactions. In: Schachner LA, Hansen RC (eds) Pediatric dermatology, 4th edn. Mosby Elsevier, London, pp 1698–1711

    Google Scholar 

  • Lewis AL, M. Klintworth E, O. Hinton J, M. Gray K (2013) Adolescent medication misuse: results from the MUSC inventory of medication experiences (MIME). Adolesc Psychiatry (Hilversum) 3(2):184–189

    Article  Google Scholar 

  • Lugo R, Ward R (2004) Basic pharmacokinetic principles. In: Polin R, Fox W, Abman S (eds) Fetal and neonatal physiology, 3rd edn. Harcourt Health Sciences, Philadelphia, pp 190–197

    Chapter  Google Scholar 

  • Macdonald JB, Macdonald B, Golitz LE, Lorusso P, Sekulic A (2015) Cutaneous adverse effects of targeted therapies. J Am Acad Dermatol 72(2):203–218, 221–236.

    Article  CAS  PubMed  Google Scholar 

  • Moore TJ, Weiss SR, Kaplan S, Blaisdell CJ (2002) Reported adverse drug events in infants and children under 2 years of age. Pediatrics 110(5):e53

    Article  PubMed  Google Scholar 

  • Morelli JG, Tay YK, Rogers M, Halbert A, Krafchik B, Weston WL (1999) Fixed drug eruptions in children. J Pediatr 134(3):365–367

    Article  CAS  PubMed  Google Scholar 

  • Murray DL, Singer DA, Singer AB, Veldman JP (1980) Cefaclor--a cluster of adverse reactions. N Engl J Med 303(17):1003

    CAS  PubMed  Google Scholar 

  • Nacaroglu HT, Celegen M, Ozek G, Umac O, Karkıner CS, Yıldırım HT, Can D (2014) Acute generalized exanthematous pustulosis induced by ceftriaxone use. Postepy Dermatol Alergol 31(4):269–271

    Article  PubMed  PubMed Central  Google Scholar 

  • Noguera-Morel L, Hernández-Martín A, Torrelo A (2014) Cutaneous drug reactions in the pediatric population. Pediatr Clin N Am 61:403–426

    Article  Google Scholar 

  • Nussinovitch M, Prais D, Ben-Amitai D, Amir J, Volovitz B (2002) Fixed drug eruption in the genital area in 15 boys. Pediatr Dermatol 19(3):216–219

    Article  PubMed  Google Scholar 

  • Okubo Y, Nochioka K, Testa MA (2017) Nationwide survey of Stevens-Johnson syndrome and toxic epidermal necrolysis in children in the United States. Pediatr Dermatol 34(2):206–208. https://doi.org/10.1111/pde.13050

    Article  PubMed  Google Scholar 

  • Ott H (2011) Chapter 183. Hypersensitivity reactions to drugs. In: Harper’s textbook of pediatric dermatology. Wiley Blackwell, Oxford

    Google Scholar 

  • Pavlos R, Mallal S, Phillips E (2012) HLA and pharmacogenetics of drug hypersensitivity. Pharmacogenomics 13(11):1285–1306

    Article  CAS  PubMed  Google Scholar 

  • Pichler WJ, Daubner B, Kawabata T (2011) Drug hypersensitivity: flare-up reactions, cross-reactivity and multiple drug hypersensitivity. J Dermatol 38(3):216–221. https://doi.org/10.1111/j.1346-8138.2010.01142.x

    Article  PubMed  Google Scholar 

  • Posso-De Los Rios CJ, Pope E (2014) New insights into pustular dermatoses in pediatric patients. J Am Acad Dermatol 70(4):767–773

    Article  PubMed  Google Scholar 

  • Rebelo Gomes E, Fonseca J, Araujo L, Demoly P (2008) Drug allergy claims in children: from self-reporting to confirmed diagnosis. Clin Exp Allergy 38(1):191–198

    CAS  PubMed  Google Scholar 

  • Romiti R, Araujo KM, Steinwurz F, Denadai R (2016) Anti-tumor necrosis factor α-related psoriatic lesions in children with inflammatory bowel disease: case report and systematic literature review. Pediatr Dermatol 33(2):e174–e178

    Article  PubMed  Google Scholar 

  • Sasidharanpillai S, Sabitha S, Riyaz N, Binitha MP, Muhammed K, Riyaz A, Jayakrishnan MP, Reyila VP (2016) Drug reaction with eosinophilia and systemic symptoms in children: a prospective study. Pediatr Dermatol 33(2):e162–e165. https://doi.org/10.1111/pde.12803

    Article  PubMed  Google Scholar 

  • Sherlock ME, Walters T, Tabbers MM, Frost K, Zachos M, Muise A, Pope E, Griffiths AM (2013) Infliximab-induced psoriasis and psoriasiform skin lesions in pediatric Crohn disease and a potential association with IL-23 receptor polymorphisms. J Pediatr Gastroenterol Nutr 56(5):512–518

    Article  CAS  PubMed  Google Scholar 

  • Smith WA, Siegel D, Lyon VB, Holland KE (2013) Psoriasiform eruption and oral ulcerations as adverse effects of topical 5% imiquimod treatment in children: a report of four cases. Pediatr Dermatol 30(6):e157–e160

    Article  PubMed  Google Scholar 

  • Star K, Noren GN, Nordin K, Edwards IR (2011) Suspected adverse drug reactions reported for children worldwide: an exploratory study using VigiBase. Drug Saf 34(5):415–428

    Article  PubMed  Google Scholar 

  • Statistics Canada 2013 http://www.statcan.gc.ca/pub/82-624-x/2013001/article/11879-eng.htm. Accessed 10 July 2017

  • t Jong GW, Vulto AG, de Hoog M et al (2000) Unapproved and off-label use of drugs in a children’s hospital. N Engl J Med 343:1125

    Article  CAS  Google Scholar 

  • Thompson DF, Ramos CL (2017) Antibiotic-induced rash in patients with infectious mononucleosis. Ann Pharmacother 51(2):154–162. https://doi.org/10.1177/1060028016669525

    Article  PubMed  Google Scholar 

  • Tsakok T, Du Toit G, Flohr C (2014) Pediatric urticaria. Immunol Allergy Clin N Am 34(1):117–139. https://doi.org/10.1016/j.iac.2013.09.008

    Article  Google Scholar 

  • Van Batavia JP, Chu DI, Long CJ, Jen M, Canning DA, Weiss DA (2017) Genitourinary involvement and management in children with Stevens-Johnson syndrome and toxic epidermal necrolysis. J Pediatr Urol 13:490.e1. https://doi.org/10.1016/j.jpurol.2017.01.018

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yaron Finkelstein .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Fridental, I., Finkelstein, Y. (2019). Cutaneous Adverse Drug Reactions in Pediatric Population. In: Shear, N., Dodiuk-Gad, R. (eds) Advances in Diagnosis and Management of Cutaneous Adverse Drug Reactions. Adis, Singapore. https://doi.org/10.1007/978-981-13-1489-6_11

Download citation

  • DOI: https://doi.org/10.1007/978-981-13-1489-6_11

  • Published:

  • Publisher Name: Adis, Singapore

  • Print ISBN: 978-981-13-1488-9

  • Online ISBN: 978-981-13-1489-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics